Table 4.
Significantly changed mean fluoresence intensity (MFI) on circulating lymphocytes and monocytes before and after eccentric exercise
| Antigen | Rest | Post | 6 h | 24 h | 48 h | 4 days | 7 days | |
|---|---|---|---|---|---|---|---|---|
| Lym CD20 sub CD5- | Exercise | 602 | 599 | 584* | 540* | 555* | 510* | 547* |
| (573–630) | (568–629) | (543–613) | (502–579) | (536–583) | (498–545) | (505–582) | ||
| Control | 571 | 583 | 563 | 541 | 517 | 530 | 511 | |
| (553–601) | (549–599) | (550–584) | (521–557) | (461–591) | (215–706) | (487–540) | ||
| Lym CD4 sub CD3+ | Exercise | 810† | 811† | 806† | 812† | 796 | 801 | 795 |
| (764–834) | (807–819) | (796–816) | (803–820) | (791–805) | (793–806) | (748–795) | ||
| Control | 799 | 796 | 791 | 790 | 796 | 802 | 791 | |
| (790–803) | (787–804) | (788–798) | (778–798) | (770–816) | (791–808) | (782–803) | ||
| Lym CD45 sub DR+ | Exercise | 708 | 694 | 699 | 703 | 703* | 701 | 698 |
| (692–717) | (679–715) | (692–712) | (689–717) | (769–714) | (691–710) | (682–708) | ||
| Control | 708 | 713 | 709 | 700* | 704 | 701 | 691 | |
| (693–726) | (693–723) | (693–725) | (686–713) | (688–718) | (692–712) | (673–711) | ||
| Lym CD8 sub CD3+ | Exercise | 625 | 619* | 609 | 606 | 599* | 597 | 593* |
| (573–699) | (580–635) | (591–629) | (578–631) | (572–609) | (559–615) | (535–613) | ||
| Control | 597 | 585 | 583 | 569 | 571 | 582 | 556 | |
| (567–627) | 585 | 583 | 569 | 571 | 582 | 556 | ||
| (567–627) | (555–622) | (546–620) | (507–658) | (486–651) | (519–630) | (517–581) | ||
| Mon CD11b sub 62L+ | Exercise | 653 | 663 | 700 | 662 | 584 | 701 | 683 |
| (567–719) | (572–723) | (595–747) | (566–728) | (511–659) | (611–745) | (544–770) | ||
| Control | 598 | 578 | 615 | 658 | 701 | 672* | 574 | |
| (472–715) | (455–729) | (483–748) | (530–754) | (572–794) | (656–724) | (501–643) | ||
| Mon CD14 sub DR+ | Exercise | 804 | 801 | 795* | 757* | 772* | 756* | 754 |
| (785–821) | (778–818) | (770–801) | (733–782) | (751–796) | (717–788) | (716–786) | ||
| Control | 787 | 781 | 782 | 760* | 743 | 744* | 751 | |
| (763–805) | (704–816) | (773–800) | (734–776) | (681–829) | (727–764) | (692–807) | ||
| Mon CD14 sub DR- | Exercise | 779 | 755 | 772 | 743 | 747* | 740* | 733 |
| (752–789) | (707–783) | (743–789) | (726–767) | (693–766) | (685–767) | (697–768) | ||
| Control | 755 | 769 | 750 | 733* | 711 | 737* | 735 | |
| (758–791) | (701–818) | (712–796) | (655–784) | (645–805) | (714–760) | (651–815) | ||
| Mon CD4 sub CD62L+ | Exercise | 690 | 697 | 631*‡ | 615* | 705†‡ | 598* | 610* |
| (669–707) | (669–704) | (595–661) | (589–669) | (657–725) | (581–646) | (577–676) | ||
| Control | 699 | 703 | 683*‡ | 654* | 583‡ | 600* | 688 | |
| (648–743) | (642–743) | (622–727) | (594–712) | (511–701) | (585–623) | (627–734) | ||
| Mon CD4 sub CD62L- | Exercise | 685 | 693 | 617* | 641 | 693† | 632* | 626* |
| (671–699) | (663–717) | (588–655) | (608–685) | (631–727) | (571–670) | (602–680) | ||
| Control | 701 | 697 | 683 | 669 | 616 | 634 | 711 | |
| (647–735) | (639–733) | (611–726) | (646–699) | (576–641) | (604–650) | (659–801) | ||
| Mon CD45 sub CD14+DR+ | Exercise | 686 | 679 | 678 | 659*‡ | 678†‡ | 657* | 659 |
| (668–698) | (661–696) | (670–686) | (628–675) | (664–699) | (632–686) | (663–700) | ||
| Control | 684 | 682 | 685 | 670‡ | 656 | 668* | 674 | |
| (670–703) | (663–701) | (657–712) | (651–684) | (642–675) | (626–685) | (630–705) | ||
| Mon CD45 sub CD14+DR- | Exercise | 650‡ | 641 | 660 | 627* | 642 | 614* | 631 |
| (631–685) | (606–662) | (642–665) | (598–644) | (611–673) | (577–653) | (595–667) | ||
| Control | 668 | 659 | 646 | 631* | 616 | 631 | 640 | |
| (657–681) | (647–678) | (614–685) | (580–670) | (599–638) | (599–648) | (585–689) |
Exercise, n = 7; control, n = 5. Data are median values with 95% confidence intervals in parentheses
†
P < 0.05 compared to control (Mann-Whitney test)
*
P < 0.05 compared to rest (Wilcoxon signed rank test); § P < 0.01 between change from rest in exercise compared to control group (Mann-Whitney test). MFI for CD antigen on phenotype subset; for example, Lym CD45 sub DR+ indicates CD45 expression on DR+ lymphocyte.